Atherosclerotic Cardiovascular Diseases Active Not Recruiting Phase 3 Trials for Obicetrapib (DB14890)
Also known as: Atherosclerotic Cardiovascular Disease / Atheromatosis / Atherosclerotic heart disease of native coronary artery / Atherosclerosis / Atherosclerosis (morphologic abnormality) / Arteriosclerotic vascular disease (disorder) / Arteriosclerosis / Arteriosclerosis (morphologic abnormality) / Vascular sclerosis (morphologic abnormality)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0078488 (Atherosclerotic Cardiovascular Diseases) | Active Not Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05202509 | Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease | Treatment | |
| NCT05142722 | Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies | Treatment |